Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4452595 | 1.00 | MAOB (0.50) | MAOBMCL1LMNAALDH1A1TRPA1 | |
| SCHEMBL7728995 | 0.84 | GRIK1 (0.39) | MAOBMCL1LMNAALDH1A1TRPA1 | |
| SCHEMBL8103328 | 0.84 | TDP1 (0.40) | MAOBMCL1LMNAALDH1A1TRPA1 | |
| SCHEMBL27635900 | 0.84 | MAOB (0.50) | MAOBMCL1LMNAALDH1A1TRPA1 | |
| SCHEMBL1614744 | 0.83 | MAOB (0.54) | MAOBMCL1LMNAALDH1A1TRPA1 | |
| SCHEMBL1614745 | 0.83 | MAOB (0.54) | MAOBMCL1LMNAALDH1A1TRPA1 | |
| SCHEMBL8103329 | 0.83 | PPARA (0.40) | MAOBMCL1LMNAALDH1A1TRPA1 | |
| SCHEMBL7728991 | 0.83 | GRIK1 (0.41) | MAOBMCL1LMNAALDH1A1TRPA1 | |
| SCHEMBL8862864 | 0.82 | GRIK1 (0.44) | MAOBMCL1LMNAALDH1A1TRPA1 | |
| SCHEMBL8103325 | 0.81 | GRIK1 (0.39) | MCL1LMNAALDH1A1MAPK1HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101405303-B | Acrylated hyaluronic acid | NOVOZYMES BIOPHARMA DK AS | 2011-11-23 | — | — | CN | disclosed |
| EP-1999160-B1 | ACRYLATED HYALURONIC ACID | NOVOZYMES BIOPHARMA DK AS (DK) | 2009-12-30 | — | — | EP | disclosed |
| US-20090118423-A1 | Acrylated Hyaluronic Acid | NOVOZYMES BIOPOLYMER A/S (DK) | 2009-05-07 | — | — | US | disclosed |
| CN-101405303-A | Acrylated hyaluronic acid | NOVOZYMES BIOPOLYMER AS (DK) | 2009-04-08 | — | — | CN | disclosed |
| EP-1999160-A2 | ACRYLATED HYALURONIC ACID | Novozymes Biopolymer A/S (DK) | 2008-12-10 | — | — | EP | disclosed |
| US-7378203-B2 | Ferrocene(di)carboxaldehyde N-phenylhydrazone and monomeric, bridged or polymeric derivatives; good mechanical and electrostatic properties; can be used with liquid and dry toners to produce high quality images; imaging systems can be maintained after repeated cycling; electrography | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-05-27 | — | — | US | disclosed |
| WO-2007106738-A2 | ACRYLATED HYALURONIC ACID | NOVOZYMES BIOPOLYMER A/S (DK) | 2007-09-20 | — | — | WO | disclosed |
| US-20060210897-A1 | Charge transport materials having at least a metallocene group | S-PRINTING SOLUTION CO., LTD. (KR) | 2006-09-21 | — | — | US | disclosed |
| US-5942387-A | Combinatorial process for preparing substituted thiophene libraries | ELI LILLY AND COMPANY (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0825164-A2 | Scavenger assisted combinatorial process for preparing libraries of amides, carbamates and sulfonamides | ELI LILLY AND COMPANY (US) | 1998-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118423-A1 | Acrylated Hyaluronic Acid | CD44, ACR, MUC1 | MAOB 1865/4885MCL1 3121/4885LMNA 2588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.